Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients (EXOTIC)
Acute Bronchitis
Enrolment: 56 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Acute Bronchitis
Enrolment: 56 · Results not recorded
COVID-19
Enrolment: 21 · Results not recorded
Potential Abnormality of Glucose Tolerance · Appetitive Behavior
Enrolment: 11 · Results not recorded
Cancer of the Head and Neck · Xerostomia · Oral Mucositis
Enrolment: 200 · Results not recorded
Aphthous Stomatitis
Enrolment: 20 · Results not recorded
Xerostomia
Enrolment: 40 · Results not recorded
Acute Coronary Syndromes (ACS)
Enrolment: 15 · Results not recorded
Effects of; Food, Allergic
Enrolment: 40 · Results not recorded
Obesity
Enrolment: 25 · Results not recorded
Patient Engagement
Enrolment: 120 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute liver injury from a single intraperitoneal dose of carbon tetrachloride in olive oil (1:3), 1 ml/kg, given 1 h after the final thyme dose on day 7
Both thyme preparations reduced hepatic lipid peroxidation and normalised antioxidant enzyme activities, but the tincture worsened serum AST and ALT while the syrup lowered them, and neither improved histological liver damage.
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.